Abstract
Bioactive peptides are promising lead structures for the development of novel drugs. However, peptides have many drawbacks for their direct use as therapeutics such as degradation by proteases and low bioavailability. These limitations can be overcome by their transformation into peptidomimetics.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hahn, M., Winker, D., Welfle, K., Misselwitz, R., Welfle, H., Wessner, H., Zahn, G., Scholz, C., Seifert, M., Hawkins, R., Schneider-Mergener, J., Höhne, W. J. Mol. Biol. 314, 293–309 (2001).
Frank, R. Tetrahedron 48, 9217–9232 (1992).
Wenschuh, H., Volkmer-Engert, R., Schmidt, M., Schulz, M., Schneider-Mergener, J., Reineke, U. Biopolymers (Peptide Sci.) 55, 188–206 (2000).
Reineke, U., Volkmer-Engert, R., Schneider-Mergener, J. Curr. Opin. Biotechnol. 12, 59–64 (2001).
Ast, T., Heine, N., Germeroth, L., Schneider-Mergener, J., Wenschuh, H. Tetrahedron Lett. 40, 4317–4318 (1999).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Reineke, U., Hoffmann, B., Ast, T., Polakowski, T., Schneider-Mergener, J., Volkmer-Engert, R. (2001). Stepwise Peptide-Peptoid Transformation via SPOT Synthesis. In: Lebl, M., Houghten, R.A. (eds) Peptides: The Wave of the Future. American Peptide Symposia, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0464-0_267
Download citation
DOI: https://doi.org/10.1007/978-94-010-0464-0_267
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3905-5
Online ISBN: 978-94-010-0464-0
eBook Packages: Springer Book Archive